Consolidated Statement Of Comprehensive Income

Solasia Pharma K.K. - Filing #7311866

Concept	2024-01-01 to 2024-06-30	2024-01-01 to 2024-06-30	2024-01-01 to 2024-06-30	2024-01-01 to 2024-06-30	2024-01-01 to 2024-06-30	2024-04-01 to 2024-06-30	2024-01-01 to 2024-06-30	2024-01-01 to 2024-06-30	2024-01-01 to 2024-06-30	2023-01-01 to 2023-06-30	2023-01-01 to 2023-06-30	2023-01-01 to 2023-06-30	2023-01-01 to 2023-06-30	2023-01-01 to 2023-06-30	2023-01-01 to 2023-06-30	2023-01-01 to 2023-06-30	2023-04-01 to 2023-06-30	2023-01-01 to 2023-06-30
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)	JPY	-611,000,000 JPY	JPY	JPY	JPY	-300,000,000 JPY	JPY	JPY	-611,000,000 JPY	JPY	JPY	-437,000,000 JPY	JPY	JPY	JPY	-437,000,000 JPY	-196,000,000 JPY	JPY
Other comprehensive income
Items that may be reclassified to profit or loss
Exchange differences on translation of foreign operations	—	10,000,000 JPY	—	—	—	0 JPY	—	—	—	—	—	7,000,000 JPY	—	—	—	—	3,000,000 JPY	—
Total of items that may be reclassified to profit or loss	—	10,000,000 JPY	—	—	—	0 JPY	—	—	—	—	—	7,000,000 JPY	—	—	—	—	3,000,000 JPY	—
Other comprehensive income	10,000,000 JPY	10,000,000 JPY	JPY	JPY	10,000,000 JPY	0 JPY	JPY	JPY	JPY	JPY	JPY	7,000,000 JPY	JPY	7,000,000 JPY	7,000,000 JPY	JPY	3,000,000 JPY	JPY
Comprehensive income	10,000,000 JPY	-600,000,000 JPY	JPY	JPY	10,000,000 JPY	-300,000,000 JPY	JPY	JPY	-611,000,000 JPY	JPY	JPY	-430,000,000 JPY	JPY	7,000,000 JPY	7,000,000 JPY	-437,000,000 JPY	-192,000,000 JPY	JPY
Comprehensive income attributable to
Owners of parent	—	-600,000,000 JPY	—	—	—	-300,000,000 JPY	—	—	—	—	—	-430,000,000 JPY	—	—	—	—	-192,000,000 JPY	—